electroCore, Inc. (ECOR)Â
NASDAQ$6.81
Market Cap
$48.98M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
201 of 919
Rank in Industry
23 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ECOR Insider Trading Activity
ECOR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $341,787 | 5 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Goldberger Daniel S | Chief Executive Officer | 2 | $256,177 | 0 | $0 | $256,177 |
| Errico Thomas J. | director | 2 | $79,180 | 0 | $0 | $79,180 |
| GANDOLFO JOHN P | director | 1 | $6,430 | 0 | $0 | $6,430 |
About electroCore, Inc.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Insider Activity of electroCore, Inc.
Over the last 12 months, insiders at electroCore, Inc. have bought $341,787 and sold $0 worth of electroCore, Inc. stock.
On average, over the past 5 years, insiders at electroCore, Inc. have bought $598,366 and sold $5,960 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Goldberger Daniel S (Chief Executive Officer) — $256,177. Errico Thomas J. (director) — $79,180. GANDOLFO JOHN P (director) — $6,430.
The last purchase of 1,000 shares for transaction amount of $8,590 was made by Goldberger Daniel S (Chief Executive Officer) on 2025‑03‑17.
List of Insider Buy and Sell Transactions, electroCore, Inc.
| 2025-03-17 | Goldberger Daniel S | Chief Executive Officer | 1,000 0.0145% | $8.59 | $8,590 | -6.54% | ||
| 2025-03-17 | Errico Thomas J. | director | 6,000 0.0818% | $8.10 | $48,585 | -6.54% | ||
| 2024-08-15 | Errico Thomas J. | director | 5,000 0.0788% | $6.12 | $30,595 | +92.49% | ||
| 2024-06-13 | GANDOLFO JOHN P | director | 1,000 0.0156% | $6.43 | $6,430 | +38.33% | ||
| 2024-06-05 | Goldberger Daniel S | Chief Executive Officer | 38,505 0.6218% | $6.43 | $247,587 | +23.23% | ||
| 2024-01-12 | POSNER BRIAN M | Chief Financial Officer | 16,000 – | $0 | $0 | +8.10% | ||
| 2023-09-15 | Goldberger Daniel S | Chief Executive Officer | 1,500 0.0246% | $5.55 | $8,333 | +8.14% | ||
| 2023-08-04 | Goldberger Daniel S | Chief Executive Officer | 50,000 – | $0 | $0 | +32.72% | ||
| 2023-08-02 | Goldberger Daniel S | Chief Executive Officer | 50,991 1.0559% | $4.35 | $221,811 | +37.90% | ||
| 2023-03-17 | Goldberger Daniel S | Chief Executive Officer | 500 0.011% | $3.43 | $1,715 | +72.80% | ||
| 2023-03-16 | Goldberger Daniel S | Chief Executive Officer | 500 0.0106% | $3.46 | $1,730 | +65.12% | ||
| 2023-03-15 | Goldberger Daniel S | Chief Executive Officer | 500 0.0108% | $3.55 | $1,775 | +63.22% | ||
| 2023-03-14 | Goldberger Daniel S | Chief Executive Officer | 500 0.011% | $3.73 | $1,865 | +59.13% | ||
| 2023-03-13 | Goldberger Daniel S | Chief Executive Officer | 500 0.0113% | $3.86 | $1,930 | +56.51% | ||
| 2022-12-14 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0071% | $0.35 | $1,749 | +2.70% | ||
| 2022-12-13 | Errico Joseph P | director | 100,000 0.1382% | $0.33 | $33,330 | +4.51% | ||
| 2022-12-13 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0068% | $0.33 | $1,649 | +4.51% | ||
| 2022-12-12 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0068% | $0.32 | $1,590 | +7.91% | ||
| 2022-12-09 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0067% | $0.30 | $1,499 | +12.61% | ||
| 2022-12-08 | Goldberger Daniel S | Chief Executive Officer | 10,000 0.0143% | $0.28 | $2,777 | +29.51% |
Total: 66
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Goldberger Daniel S | Chief Executive Officer | 290565 4.0395% | $1.98M | 19 | 0 | +21.45% |
| Errico Thomas J. | director | 256401 3.5645% | $1.75M | 11 | 0 | <0.0001% |
| GANDOLFO JOHN P | director | 50704 0.7049% | $345,294.24 | 3 | 0 | <0.0001% |
| Merck Global Health Innovation Fund, LLC | 10 percent owner | 3346032 46.5173% | $22.79M | 1 | 0 | <0.0001% |
| Errico Joseph P | director | 2724841 37.8814% | $18.56M | 10 | 6 | +12.97% |
| TULLIS JAMES L L | director | 1764705 24.5333% | $12.02M | 3 | 0 | |
| Moody Trevor J | 423455 5.887% | $2.88M | 3 | 0 | <0.0001% | |
| Amato Francis R. | Chief Executive Officer | 358831 4.9886% | $2.44M | 1 | 0 | <0.0001% |
| Staats Peter S. | Chief Medical Officer | 154636 2.1498% | $1.05M | 1 | 0 | <0.0001% |
| POSNER BRIAN M | Chief Financial Officer | 22437 0.3119% | $152,795.97 | 4 | 1 | <0.0001% |
| COX CARRIE SMITH | director | 21000 0.2919% | $143,010.00 | 3 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
ECOR Institutional Investors: Active Positions
| Increased Positions | 17 | +68% | 222,589 | +14.69% |
| Decreased Positions | 8 | -32% | 851,002 | -56.16% |
| New Positions | 11 | New | 97,370 | New |
| Sold Out Positions | 2 | Sold Out | 18,068 | Sold Out |
| Total Postitions | 34 | +36% | 886,868 | -41.47% |
ECOR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $1,351.00 | 2.41% | 168,924 | 0 | 0% | 2024-12-31 |
| Awm Investment Company, Inc. | $1,305.00 | 2.33% | 163,133 | -346,961 | -68.02% | 2024-12-31 |
| Renaissance Technologies Llc | $1,054.00 | 1.88% | 131,786 | +58,800 | +80.56% | 2024-12-31 |
| Geode Capital Management, Llc | $488.00 | 0.87% | 61,044 | -2,441 | -3.85% | 2024-12-31 |
| International Assets Investment Management, Llc | $427.00 | 0.76% | 53,370 | -481,776 | -90.03% | 2024-12-31 |
| Wealthspire Advisors, Llc | $380.00 | 0.68% | 47,524 | +26 | +0.06% | 2024-12-31 |
| State Street Corp | $290.00 | 0.52% | 36,272 | +24,600 | +210.76% | 2024-12-31 |
| Hightower Advisors, Llc | $283.00 | 0.51% | 35,342 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $275.00 | 0.49% | 34,357 | +22,776 | +196.67% | 2024-12-31 |
| Marshall Wace, Llp | $216.00 | 0.39% | 26,997 | +26,997 | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.